IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1056
Positioning
Market Dominance
Services
Healthcare
$9.5B
Javier J. Rodriguez
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients. The company provides acute inpatient dialysis. services in approximately 850 hospitals and related laboratory services.
Headcount
70.0K
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = DVA ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$DVA DAVITA INC. | 57 | 55 | 76 | 54 | 9.7x | 3.7x | 77.5% | 6.0% | 32.0% | 15.2% | 7.9% | 7.3% | 0.0% | - | $9.5B | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
DAVITA INC. (DVA) receives a "Hold" rating with a composite score of 56.8/100. It ranks #1056 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Direct cash return
Javier J. Rodriguez
Chief Executive Officer
Labor Force
70,000
55
43
71
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for DVA
HQ Base
Wilmington, Colorado
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for DVA.
View All RatingsNet income exceeding cash flow (Accrual bloat detected)
Material decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 55 | 68 | -13DRAG |
| MOMENTUM | 54 | 55 | -1NEUTRAL |
| VALUATION | 76 | 86 | -10DRAG |
| INVESTMENT | 43 | 75 | -32DRAG |
| STABILITY | 71 | 77 | -6DRAG |
| SHORT INT | 34 | 23 | +11ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 18.1% vs WACC 5.5% (spread +12.6%)
GM 32% vs sector 60%, OM 15% vs sector 4%
Capital turnover 1.43x
Rev growth 7%, 10yr history
Interest coverage 13.1x, Net debt/EBITDA 3.5x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns DAVITA INC. a Hold rating, with a composite score of 56.8/100 and 3 out of 5 stars. Ranked #1056 of 7,333 stocks, DVA presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 55/100, DVA shows adequate but unremarkable business quality. The company reports a return on equity of 77.5% (sector avg: 5.3%), gross margins of 32.0% (sector avg: 59.6%), net margins of 7.9% (sector avg: 2.3%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
DVA carries a solid value score of 76/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 9.66x, an EV/EBITDA of 3.69x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
With an investment score of 43/100, DVA exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 7.3% vs. a sector average of 7.8% and a return on assets of 6.0% (sector: 1.9%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
DVA demonstrates moderate momentum with a score of 54/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at 7.3% year-over-year, while a beta of 0.35 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
DVA shows good financial stability with a score of 71/100. Key stability metrics include a beta of 0.35. This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
DAVITA INC.'s short interest score of 34/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. At $9.5B (mid-cap), DVA carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
DAVITA INC. is a mid-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #1056 of 7,333 overall (86th percentile). Key comparisons include ROE of 77.5% exceeding the 5.3% sector median and operating margins of 15.2% above the 3.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While DVA currently exhibits a HOLD profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Key factor gap
Value (76) vs Short Int. (34) — closing this gap could shift the rating.
EV/EBITDA 69% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 1359% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 46% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate DAVITA INC. (DVA) as a Hold with a composite score of 56.8/100 at a current price of $150.92. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in value (76th percentile) and stability (71th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a Narrow Moat rating (54/100), Low uncertainty, and Standard capital allocation.
Key items to watch: quarterly earnings execution and sector-level competitive dynamics. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
DAVITA INC. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 56.8/100 places it at rank #1056 in our full 7,333-stock universe. At $9.5B in market capitalization, DAVITA INC. is a mid-cap player in the Services space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 7%, though momentum at the 54th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 32% (-27.6pp vs sector) narrow to operating margins of 15% (+11.7pp vs sector) and net margins of 7.9%, yielding a gross-to-net conversion rate of 25%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $150.92, DAVITA INC. appears undervalued relative to its fundamentals. Our value factor score of 76/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 9.7x (a 59% discount to the sector median of 23.7x), EV/EBITDA of 3.7x (discounted to peers), P/S of 0.8x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Returns on equity of 77.5% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
A value factor score of 76/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Even high-quality stocks face risks from valuation compression, competitive disruption, or macro shocks that are difficult to quantify in advance.
We assign a Low uncertainty rating to DAVITA INC.. The company exhibits strong financial stability with a beta of 0.35, and a stability factor in the 71th percentile. The predictable nature of the business model and solid financial position reduce the range of potential outcomes, giving us confidence in our fair value estimate.
Specific risk factors that inform our assessment include: low beta of 0.35 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 71th percentile and quality factor at the 55th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: above-average stability (71th percentile) suggests predictable business dynamics. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate DAVITA INC.'s capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 77.5%, and the balance sheet is managed within acceptable parameters (D/E: N/A). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; DAVITA INC. falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. Absent a dividend, the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, DAVITA INC. receives a Hold rating with a composite score of 56.8/100 (rank #1056 of 7,333). Our quantitative framework assigns a Narrow Moat (54/100, trend: stable), Low uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 60/100.
Our analysis supports a neutral stance on DAVITA INC.. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign DAVITA INC. a Narrow Moat rating with a composite moat score of 54/100. The ROIC-WACC spread of +12.6% is the primary signal of economic value creation. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that DAVITA INC. can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being financial resilience at 15.2/20.
The strongest moat sources are financial resilience (15.2/20) and economic value creation (14/20). Interest coverage 13.1x, Net debt/EBITDA 3.5x. ROIC 18.1% vs WACC 5.5% (spread +12.6%). These pillars form the core of DAVITA INC.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (3.7/20) and growth durability (9.3/20). Capital turnover 1.43x. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect DAVITA INC.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include operating margins of 15% reflecting effective cost management, moderate revenue growth of 7%, returns on equity of 77.5% driving shareholder value creation. The margin cascade from 32% gross to 15% operating to 7.9% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 55th percentile.
The margin profile shows gross margins of 32%, operating margins of 15%, net margins of 7.9%. Return metrics include ROE of 77.5% and ROA of 6.0%. Relative to the Services sector, gross margins are 27.6 percentage points below the sector median of 60%, and ROE of 77.5% compares to a sector median of 5.3%.
The balance sheet reflects revenue growth of 7%. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081

The Q1 2025 earnings season has seen mostly positive results from S&P 500 companies, with 78% beating Wall Street's expectations. However, some consumer-facing companies like Wynn, Clorox, and Restaurant Brands International reported weaker-than-anticipated profits and revenues, suggesting potential cracks in consumer spending.

Greg Abel, the new CEO of Berkshire Hathaway, has made his first reported stock sale by divesting 1.7 million shares of DaVita under a contractual agreement. The article also highlights Kraft Heinz as a potential candidate for sale, as Abel has registered to sell nearly all of Berkshire's 325 million shares and expressed disapproval of the company's planned split into two entities.

The article highlights three healthcare stocks trading at attractive valuations: DaVita, Merck, and Universal Health Services, which offer potential investment opportunities despite current market challenges.
Earlier in February 2026, DaVita Inc. completed two major share repurchase tranches under its 2020 and 2024 buyback programs, retiring millions of shares for a combined outlay of more than US$5.63 billion. This large-scale reduction in share count, alongside CEO Javier Rodriguez’s upcoming appearance at the ViVE 2026 conference in Los Angeles, highlights how DaVita is pairing capital returns with a focus on its long-term care and technology agenda. We’ll now examine how the completion of...

The article analyzes three Berkshire Hathaway holdings: DaVita and Kraft Heinz are recommended as strong buys due to positive earnings surprises and undervaluation, while UnitedHealth Group should be avoided despite recent dips, as it trades at a premium valuation with a deteriorating growth story amid lower Medicare Advantage payment increases.